COVID-19 Treatment and Medication
Marco Goeijenbier, Rik Endeman, Michael Ison, Brooke Nichols, Ab Osterhaus
October 4 2021
Third webinar in the series: Preparing for COVID-19, RSV disease and Inlfuenza concomitant outbreaks, chaired by Ab Osterhaus and Marco Goeijenbier
Including: - Sprint though the most recent COVID-19 literature on treatment options - Cost-effectiveness of dexamethasone, tocilzumab and remdesivir in ICU patients with COVID - Anti-viral treatment of COVID-19 - Immune modulatory treatment in severe COVID-19
